Cocoon Pharmaceuticals Private Limited
About Cocoon Pharmaceuticals Private Limited
Data last updated:
Cocoon Pharmaceuticals Private Limited is a private limited company based in Titwala, Maharashtra, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 16 October 2020.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC348076.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Sudha Kumar and Priyanka Kumari.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Vinayak Park Co Housing Society – A Flat No. 601 Vasundhri Road Manda, Titwala, Maharashtra, India – 421605.
As per the financials filed for FY 2022, the company reported a revenue of ₹12.18 Lakh. For the same year it recorded a net loss of ₹12,585 (net margin -1%) and EBITDA of ₹13,456 (EBITDA margin 1.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressVinayak Park Co Housing Society – A Flat No. 601 Vasundhri Road Manda, Titwala, Maharashtra, India – 421605
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Cocoon Pharmaceuticals Private Limited
The main business activity of Cocoon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Cocoon Pharmaceuticals Private Limited FY 2022 filings available
Cocoon Pharmaceuticals Private Limited reported revenue of ₹12.18 Lakh for FY 2022.
Financial Statement Summary of Cocoon Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹13,456 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹12,585 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Cocoon Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1.1% | •••• |
| Net Profit Margin | -1% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Cocoon Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Cocoon Pharmaceuticals Private Limited
Cocoon Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudha Kumar | Director | 20 Jun 2022 | 4 Years 4 Months | Current |
| Priyanka Kumari | Director | 16 Oct 2020 | 6 Years 0 Months | Current |
| Simmi Kumari Verma | Director | 16 Oct 2020 | 6 Years 0 Months | Current |
Peer Comparison of Cocoon Pharmaceuticals Private Limited
Cocoon Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jovian Pharmaceuticals Private Limited' | ₹12.25 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | Lake Road Noora Hazaribagh, Jharkhand, India |
| Awwa Pharmaceuticals Private Limited | ₹12.24 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Navi Mumbai, Maharashtra, India |
| Deltacure Pharmaceuticals Private Limited | ₹12.21 Lakh (FY 2025) | •••• | •••• | 26.0% | •••• | Jehanabad, Bihar, India |
| Moseley Pharmaceuticals Private Limited | ₹12.2 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Lucknow, Uttar Pradesh, India |
| Riddhi Pharmaceuticals Limited | ₹12.2 Lakh (FY 2025) | •••• | •••• | 460139.0% | •••• | Mumbai, Maharashtra, India |
| Cocoon Pharmaceuticals Private Limited this company | ₹12.18 Lakh (FY 2022) | •••• | •••• | •••• | Titwala, Maharashtra, India | |
| Savioris Pharmaceuticals Private Limited | ₹12.17 Lakh (FY 2025) | •••• | •••• | 42.0% | •••• | Jaipur, Rajasthan, India |
| Kotac Pharmaceuticals Private Limited | ₹12.17 Lakh (FY 2024) | •••• | •••• | -58.0% | •••• | Budaun, Uttar Pradesh, India |
| Bexley Pharmaceuticals Private Limited | ₹12.16 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Rimax Pharmaceuticals Private Limited | ₹12.11 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Siddson Pharmaceuticals Private Limited | ₹12.11 Lakh (FY 2025) | •••• | •••• | •••• | Belgaum, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Cocoon Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Cocoon Pharmaceuticals Private Limited
Cocoon Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Cocoon Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Cocoon Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Cocoon Pharmaceuticals Private Limited
Cocoon Pharmaceuticals Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Sudha Kumar was appointed as Director on 20 Jun 2022.
Credit Ratings, Litigation & Regulatory Alerts for Cocoon Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cocoon Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cocoon Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Cocoon Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cocoon Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cocoon Pharmaceuticals Private Limited
Cocoon Pharmaceuticals is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Cocoon Pharmaceuticals is a company pending strike off, currently registered as a private limited company based in Titwala, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 16 October 2020 and is registered under CIN U51909MH2020PTC348076. The company may be struck off soon - caution is advised.
Cocoon Pharmaceuticals has 3 current directors:
- Sudha Kumar - Director
- Priyanka Kumari - Director
- Simmi Kumari Verma - Director
The CIN (Corporate Identification Number) of Cocoon Pharmaceuticals is U51909MH2020PTC348076. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cocoon Pharmaceuticals was incorporated on 16 October 2020. It is registered with the Registrar of Companies, Mumbai.
The registered office of Cocoon Pharmaceuticals is at Vinayak Park Co Housing Society – A Flat No. 601 Vasundhri Road Manda, Titwala, Maharashtra, India – 421605.
Cocoon Pharmaceuticals reported revenue of ₹12.18 Lakh for FY 2022.
Cocoon Pharmaceuticals has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh.
Cocoon Pharmaceuticals reported a net loss of ₹12,585 (net margin -1%) and EBITDA of ₹13,456 (EBITDA margin 1.1%) for FY 2022, as per its filed financial statements.
Cocoon Pharmaceuticals operates in the trading industry, in the specialty segment.
No. Cocoon Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.